wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
David Dejardin
David Dejardin
Item
http://www.wikidata.org/entity/Q84082972
Q84082972
about
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).
Joint modeling of progression-free survival and death in advanced cancer clinical trials.
P50
Q37692798-F1C80FC6-BBDF-4F18-8E9E-D50256B91ECE
Q37767197-2CCF5E22-9512-490C-BC8C-969CFEFC0D5A
P50
David Dejardin
Item
http://www.wikidata.org/entity/Q84082972
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
David Dejardin
@en
David Dejardin
@nl
type
Item
label
David Dejardin
@en
David Dejardin
@nl
prefLabel
David Dejardin
@en
David Dejardin
@nl
P31
Q84082972-01C60D72-5C79-49F1-99E6-323691B01A31
P496
Q84082972-62E90D28-31B3-4613-A799-3FEF1E208EE7
P496
0000-0001-8960-5345
P31
Afgan
P496
0000-0001-8960-5345
http://www.w3.org/2001/XMLSchema#string